InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Discover the detailed record of transactions filed by SCHLEIFER LEONARD S, Chairman & CEO. Director active across 1 companies, notably Regeneron Pharmaceuticals, INC.. Aggregated, 10 filings have been recorded. Total volume traded: €227.1m. The latest transaction was filed on 5 April 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
€3m4,461 shares@ €651.03780.0040% mcap0.8% of flow
Common Stock
SEC:0001883850-22-000038:0·
€2m2,886 shares@ €641.24550.0025% mcap0.5% of flow
Common Stock
SEC:0001883850-22-000036:0·
€57m239,063 shares@ €237.87840.078% mcap31.8% of flow
Common Stock
SEC:0001883850-21-000009·
€57m239,063 shares@ €237.87840.078% mcap15.7% of flow
Common Stock
SEC:0001883850-21-000009:0·
€111m200,000 shares@ €555.42460.15% mcap62.2% of flow
Common Stock
SEC:0001708138-21-000064·
€111m200,000 shares@ €555.42460.15% mcap30.7% of flow
Common Stock
SEC:0001708138-21-000064:0·
€89,353171 shares@ €522.53190.0001% mcap0.1% of flow
Common Stock
SEC:0001708138-21-000058·
€89,353171 shares@ €522.53190.0001% mcap0.0% of flow
Common Stock
SEC:0001708138-21-000058:0·
€11m240,000 shares@ €43.96010.014% mcap5.9% of flow
Common Stock
SEC:0001708138-21-000048·
€11m240,000 shares@ €43.96010.014% mcap2.9% of flow
Common Stock
SEC:0001708138-21-000048:0·
10 of 10 declarations
About SCHLEIFER LEONARD S
Leonard S. Schleifer is the President & CEO of REGENERON PHARMACEUTICALS, INC. He leads the company with a strong focus on innovation in the pharmaceutical field. Leonard is recognized for his ability to transform ideas into therapeutic solutions that improve patients' lives.
